Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria
AbstractLamin A is a component of the nuclear lamina mutated in a group of human inherited disorders known as laminopathies. Among laminopathies, progeroid syndromes and lipodystrophies feature accumulation of prelamin A, the precursor protein which, in normal cells, undergoes a multi-step processing to yield mature lamin A. It is of utmost importance to characterize the prelamin A form accumulated in each laminopathy, since existing evidence shows that drugs acting on protein processing can improve some pathological aspects.We report that two antibodies raised against differently modified prelamin A peptides show a clear specificity to full-length prelamin A or carboxymethylated farnesylated prelamin A, respectively. Using these antibodies, we demonstrated that inhibition of the prelamin A endoprotease ZMPSTE24 mostly elicits accumulation of full-length prelamin A in its farnesylated form, while loss of the prelamin A cleavage site causes accumulation of carboxymethylated prelamin A in progeria cells. These results suggest a major role of ZMPSTE24 in the first prelamin A cleavage step.
- Abstract views: 453
- PDF: 248
Copyright (c) 2009 S Dominici, V Fiori, M Magnani, E Schena, C Capanni, D Camozzi, MR Dâ€™Apice, C Le Dour, M Auclair, M Caron, G Novelli, C Vigouroux, NM Maraldi, G Lattanzi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.